Characterization of p21Ras-Mediated Apoptosis Induced by Protein Kinase C Inhibition and Application to Human Tumor Cell Lines

Journal of Cellular Physiology

Volumn 198, Issue 2, 2004, Pages 277-294

  Liou, James S ^a   Chen, James S ^a   Faller, Douglas V ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; K RAS PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN P21; 1 O HEXADECYL 2 O METHYLGLYCEROL; 1-O-HEXADECYL-2-O-METHYLGLYCEROL; ENZYME INHIBITOR; GLYCEROL ETHER; HRAS PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN 3T3; CELL SURVIVAL; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINASE INHIBITION; SIGNAL TRANSDUCTION; ANIMAL; CELL MEMBRANE POTENTIAL; CHO CELL; COMPARATIVE STUDY; CRICETULUS; DRUG ANTAGONISM; DRUG EFFECT; HAMSTER; LEUKEMIA CELL LINE; MITOCHONDRION; MUTATION; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

AGOUTI PACA; MUS MUSCULUS;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME INHIBITORS; GENES, RAS; GLYCERYL ETHERS; HUMANS; JURKAT CELLS; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; MUTATION; NIH 3T3 CELLS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 1542574589     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10409     Document Type: Article

References (157)

1. Adler V, Yin ZM, Tew KD, Ronai Z. 1999. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18:6104-6111.
2. Anderson KM, Seed T, Ou D, Harris JE. 1999. Free radicals and reactive oxygen species in programmed cell death. Med Hypotheses 52:451-463.
3. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P, Karin M. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739.
4. Arase Y, Hiwasa T, Hasegawa R, Nomura J, Ito H, Suzuki N. 2000. Prevention of v-Ha-ras-dependent apoptosis by PDGF coordinates in phosphorylation of ERK and Akt. Biochem Biophys Res Commun 267:33-39.
5. Ayllon V, Rebollo A. 2000. Ras-induced cellular events (review). Mol Membr Biol 17:65-73.
6. Balmain A. 1985. Transforming ras oncogenes and multistage carcinogenesis. Br J Cancer 51:1-7.
7. Basu S, Bayoumy S, Zhang Y, Lozano J, Kolesnick R. 1998. BAD enables ceramide to signal apoptosis via Ras and Raf-1. J Biol Chem 273:30419-30426.
8. Becker D, Beebe SJ, Herlyn M. 1990. Differential expression of protein kinase C and cAMP-dependent protein kinase in normal human melanocytes and malignant melanomas. Oncogene 5:1133-1139.
9. Beraud C, Henzel WJ, Baeuerle PA. 1999. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappa B activation. Proc Natl Acad Sci USA 96:429-434.
10. Bos JL. 1989. Ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689.
11. Brooks DG, James RM, Patek CE, Williamson J, Arends MJ. 2001. Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19(ARF). Oncogene 20:2144-2152.
12. Chen CY, Faller DV. 1995. Direction of p21(ras)-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 11:1487-1498.
13. Chen CY, Faller DV. 1996. Phosphorylation of Bcl-2 protein and association with p21(Ras) in Ras-induced apoptosis. J Biol Chem 271:2376-2379.
14. Chen CY, Faller DV. 1999. Selective inhibition of protein kinase C isozymes by Fas ligation. J Biol Chem 274:15320-15328.
15. Chen CY, Forman LW, Faller DV. 1996. Calcium-dependent immediate-early gene induction in lymphocytes is negatively regulated by p21(Ha-ras). Mol Cell Biol 16:6582-6592.
16. Chen G, Shu JY, Stacey DW. 1997. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide. Oncogene 15:1643-1651.
17. Chen CY, Liou J, Forman LW, Faller DV. 1998a. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras. Cell Death Diff 5:984-995.
18. Chen CY, Liou J, Forman LW, Faller DV. 1998b. Differential regulation of discrete apoptotic pathways by Ras. J Biol Chem 273:16700-16709.
19. Chen CY, Juo P, Liou J, Yu Q, Blenis J, Faller DV. 2001. Activation of FADD and Caspase 8 in Ras-mediated apoptosis. Cell Growth Differ 12:297-306.
20. Cheng AL, Chuang SE, Fine RL, Yeh KH, Liao CM, Lay JD, Chen DS. 1998. Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochem Pharmacol 55:523-531.
21. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW, Cordon-Cardo C, Yancopoulos GD, Depinho RA. 1999. Essential role for oncogenic Ras in tumour maintenance. Nature 400:468-472.
22. Chmura SJ, Nodzenski E, Crane MA, Virudachalam S, Hallahan DE, Weichselbaum RR, Quintans J. 1996. Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231. Adv Exp Med Biol 406:39-55.
23. Chou CC, Yung BY. 1997. Anti-apoptotic effect of ras in the apoptosis induced by serum deprivation and exposure to actinomycin D. Naunyn Schmiedebergs Arch Pharmacol 355:177-182.
24. Chu ZL, Mckinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control. Proc Natl Acad Sci USA 94:10057-10062.
25. Clark GJ, Westwick JK, Der CJ. 1997. p120 GAP modulates Ras activation of Jun kinases and transformation. J Biol Chem 272:1677-1681.
26. Cox AD, Der CJ. 1997. Farnesyltransferase inhibitors and cancer treatment: Targeting simply Ras? Bba Rev Cancer 1333:F51-F71.
27. Datta SR, Dudek H, Tao X, MAsters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
28. Davis RJ. 1993. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556.
29. Davis MA, Chang SH, Trump BF. 1996. Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis. Toxicol Appl Pharm 141:93-101.
30. Deacon EM, Pongracz J, Griffiths G, Lord JM. 1997. Isoenzymes of protein kinase C: Differential involvement in apoptosis and pathogenesis. Mol Pathol 50:124-131.
31. Delpeso L, Gonzalezgarcia M, Page C, Herrera R, Nunez G. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687-689.
32. Denis GV, Yu Q, Li H, Faller DV, Chen CY. 2003. Bcl-2 targets Ras-apoptotic signaling to mitochondria via its BH4 domain. J Biol Chem 278:5775-5785.
33. deRooij J, Bos JL. 1997. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene 14:623-625.
34. Di Jeso B, Ulianich L, Racioppi L, Darmiento FP, Feliciello A, Pacifico F, Consiglio E, Formisano S. 1995. Serum withdrawal induces apoptotic cell death in Ki-ras transformed but not normal differentiated thyroid cells. Biochem Biophys Res Commun 214:819-824.
35. Diaz-Meco MT, Lozano J, Municio MM, Berra E, Frutos S, Sanz L, Moscat J. 1994. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J Biol Chem 269:31706-31710.
36. Donjerkovic D, Scott DW. 2000. Activation-induced cell death in B lymphocytes. Cell Res 10:179-192.
37. Dooley NP, Baltuch GH, Groome N, Villemure JG, Yong VW. 1998. Apoptosis is induced in glioma cells by antisense oligonucleotides to protein kinase C alpha and is enhanced by cycloheximide. Neuroreport 9:1727-1733.
38. Downward J. 1997. Cell cycle: Routine role for Ras. Curr Biol 7: R258-R260.
39. Downward J. 1998. Ras signalling and apoptosis. Curr Opin Genet Dev 8:49-54.
40. Duke RC, Witter RZ, Nash PB, Young JDE, Ojcius DM. 1994. Cytolysis mediated by ionophores and pore-forming agents-Role of intracellular calcium in apoptosis. FASEB J 8:237-246.
41. Embade N, Valeron PF, Aznar S, LopezCollazo E, Lacal JC. 2000. Apoptosis induced by Rac GTPase correlates with induction of FasL and ceramides production. Mol Biol Cell 11:4347-4358.
42. Esteve P, Embade N, Perona R, Jimenez B, Delpeso L, Leon J, Arends M, Miki T, Lacal JC. 1998. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway. Oncogene 17:1855-1869.
43. Evans CA, Lord JM, Owen-Lynch PJ, Johnson G, Dive C, Whetton AD. 1995. Suppression of apoptosis by v-ABL protein tyrosine kinase is associated with nuclear translocation and activation of protein kinase C in an interleukin-3-dependent haemopoietic cell line. J Cell Sci 108:2591-2598.
44. Fernandes RS, McGowan AJ, Cotter TG. 1996. Mutant H-ras overexpression inhibits drug and U.V. induced apoptosis. Anticancer Res 16:1691-1705.
45. Fernandez A, Fosdick LJ, Marin MC, Diaz C, Mcdonnell TJ, Ananthaswamy HN, McConkey DJ. 1995. Differential regulation of endogenous endonuclease activation in isolated murine fibroblast nuclei by ras and bcl-2. Oncogene 10:769-774.
46. Foo SY, Nolan GP. 1999. NF-kappa B to the rescue-RELs, apoptosis and cellular transformation. Trends Genet 15:229-235.
47. Fritz G, Kaina B. 2000. Ras-related GTPase RhoB forces alkylation-induced apoptotic cell death. Biochem Biophys Res Commun 268:784-789.
48. Fu T, Sugimoto Y, Oki T, Murakami S, Nozawa Y. 1991. Calcium oscillation associated with reduced protein kinase C activities in ras-transformed NIH-3T3 cells. Exp Cell Res 203:230-235.
49. Gerner C, Frohwein U, Gotzmann J, Bayer E, Gelbmann D, Bursch W, SchulteHermann R. 2000. The Fas-induced apoptosis analyzed by high throughput proteome analysis. J Biol Chem 275:39018-39026.
50. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, Pandey P, Datta R, Huang Y, Kharbanda S, Allen H, Kamen R, Wong W, Kufe D. 1996. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 184:2399-2404.
51. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, Sanchez I. 1997. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 94:3302-3307.
52. Gomez J, Martineza C, Fernandez B, Garcia A, Rebollo A. 1997. Ras activation leads to cell proliferation or apoptotic cell death upon interleukin-2 stimulation or lymphokine deprivation, respectively. Eur J Immunol 27:1610-1618.
53. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D. 1995. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2:341-351.
54. Hall-Jackson CA, Jones T, Eccles NG, Dawson TP, Bond JA, Gescher A, Wynford-Thomas D. 1998. Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: A potential therapeutic target. Br J Cancer 78:641-651.
55. Henkemeyer M, Rossi DJ, Holmyard DP, Puri MC, Mbamalu G, Harpal K, Shih TS, Jacks T, Pawson T. 1995. Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. Nature 377:695-701.
56. Herbert JM. 1993. Protein kinase C: A key factor in the regulation of tumor cell adhesion to the endothelium. Biochem Pharmacol 45:527-537.
57. Hermens AF, Bentvelzen PA. 1992. Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line. Cancer Res 52:3073-3082.
58. Hofer F, Fields S, Schneider C, Martin GS. 1994. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA 91:11089-11093.
59. Holmstrom TH, Tran SEF, Johnson VL, Ahn NG, Chow SC, Eriksson JE. 1999. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Mol Cell Biol 19:5991-6002.
60. Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Barrington RE, Windle JJ. 1997. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors. Cancer Res 57:600-603.
61. Illera VA, Perandones CE, Stunz LL, Mower DA, Ashman RF. 1993. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol 151:2965-2973.
62. Irani K, GoldschmidtClermont PJ. 1998. Ras, superoxide and signal transduction. Biochem Pharmacol 55:1339-1346.
63. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 66:233-243.
64. Jansen B, SchlagbauerWadl H, Eichler HG, Wolff K, Vanelsas A, Schrier PI, Pehamberger H. 1997. Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis. Cancer Res 57:362-365.
65. Joneson T, Barsagi D. 1999. Suppression of Ras-induced apoptosis by the Rac GTPase. Mol Cell Biol 19:5892-5901.
66. Jun CD, Oh CD, Kwak HJ, Pae HO, Yoo JC, Choi BM, Chun JS, Park RK, Chung HT. 1999. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: Involvement of c-Jun N-terminal kinase stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. J Immunol 162:3395-3401.
67. Kane LP, Shapiro VS, Stokoe D, Weiss A. 1999. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 9:601-604.
68. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544-548.
69. Khosravi-Far R, Cox AD, Kato K, Der CJ. 1992. Protein prenylation: Key to ras function and cancer intervention? Cell Growth Differ 3:461-469.
70. Khwaja A, Tatton L. 1999. Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J Biol Chem 274:36817-36823.
71. Khwaja A, Rodriguezviciana P, Wennstrom S, Warne PH, Downward J. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16:2783-2793.
72. Kinoshita T, Yokota T, Arai KI, Miyajima A. 1995. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogene 10:2207-2212.
73. Kinoshita T, Shirouzu M, Kamiya A, Hashimoto K, Yokoyama S, Miyajima A. 1997. Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL3-dependent hematopoietic cells. Oncogene 15:619-627.
74. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR. 1993. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364:249-252.
75. Koo HM, Monks A, Mikheev A, Rubinstein LV, GrayGoodrich M, McWilliams MJ, Alvord WG, Oie HK, Gazdar AF, Paull KD, Zarbl H, Vandewoude GF. 1996. Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer Res 56:5211-5216.
76. Koo HM, Gray-Goodrich M, Kohlhagen G, McWilliams MJ, Jeffers M, Vaigro-Wolff A, Alvord WG, Monks A, Paull KD, Pommier Y, Vande Woude GF. 1999a. The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis. J Natl Cancer Inst 91:236-244.
77. Koo HM, McWilliams MJ, Alvord WG, Vande Woude GF. 1999b. Ras oncogene-induced sensitization to 1-beta-n-arabinofuranosylcytosine. Cancer Res 59:6057-6062.
78. Kumar R, Sukumar S, Barbacid M. 1990. Activation of ras oncogenes preceding the onset of neoplasia. Science 248:1101-1103.
79. Kuribara R, Kinoshita T, Miyajima A, Shinjyo T, Yoshihara T, Inukai T, Ozawa K, Look AT, Inaba T. 1999. Two distinct interleukin-3-mediated signal pathways, Ras-NFIL3 (E4BP4) and Bcl-x(L), regulate the survival of murine pro-B lymphocytes. Mol Cell Biol 19:2754-2762.
80. Lan L, Wong NS. 1999. Phosphatidylinositol 3-kinase and protein kinase C are required for the inhibition of caspase activity by epidermal growth factor. FEBS Lett 444:90-96.
81. Lau QC, Brusselbach S, Muller R. 1998. Abrogation of c-Raf expression induces apoptosis in tumor cells. Oncogene 16:1899-1902.
82. Lee JY, Hannun YA, Obeid LM. 1996. Ceramide inactivates cellular protein kinase Cα. J Biol Chem 271:13169-13174.
83. Li PM, Fukazawa H, Yamamoto C, Mizuno S, Tanaka K, Hori M, Yaginuma S, Saito T, Uehara Y. 1993. Method of identifying inhibitors of oncogenic transformation: Selective inhibition of cell growth in serum-free medium. Oncogene 8:1731-1735.
84. Lin HJL, Eviner V, Prendergast GC, White E. 1995. Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 15:4536-4544.
85. Ling CC, Endlich B. 1989. Radioresistance induced by oncogenic transformation. Radiat Res 120:267-279.
86. Liou JS, Chen CY, Chen JS, Faller DV. 2000. Oncogenic Ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. J Biol Chem 275:39001-39011.
87. Liu ZG, Hsu HL, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa B activation prevents cell death. Cell 87:565-576.
88. Liu HS, Chen CY, Lee CH, Chou YI. 1998. Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells. Brit J Cancer 77:1777-1786.
89. Lowy DR, Willumsen BM. 1993. Function and regulation of RAS. Annu Rev Biochem 62851:891-891.
90. Lucas M, Sanchezmargalet V, Sanz A, Solano F. 1994. Protein kinase C activation promotes cell survival in mature lymphocytes prone to apoptosis. Biochem Pharmacol 47:667-672.
91. Ma P, Magut M, Chen X, Chen CY. 2002. P53 is necessary for the apoptotic response mediated by a transient increase of Ras activity. Mol Cell Biol 22:2928-2938.
92. Macho A, Decaudin D, Castedo M, Hirsch T, Susin SA, Zamzami N, Kroemer G. 1996. Chloromethyl-X-Rosamine is an aldehyde-fixable potential-sensitive fluorochrome for the detection of early apoptosis. Cytometry 25:333-340.
93. Madrid LV, Wang CY, Guttridge DC, Schottelius AJG, Baldwin AS, Mayo MW. 2000. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappa B. Mol Cell Biol 20:1626-1638.
94. Mansat V, Laurent G, Levade T, Bettaieb A, Zaffrezou JP. 1997. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res 57:5300-5304.
95. Marte BM, Downward J. 1997. PKB/Akt: Connecting PI3-kinase to cell survival and beyond. Trends Biochem Sci 22:355-358.
96. Mayo MW, Wang CY, Cogswell PC, RogersGraham KS, Lowe SW, Der CJ, Baldwin AS. 1997. Requirement of NF-kappa B activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278:1812-1815.
97. McConkey DJ, Hartzell P, Jondal M, Orrenius S. 1989. Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C. J Biol Chem 264:13399-13402.
98. Mccormick F. 1998. Signal transduction-Why Ras needs Rho. Nature 394:220-221.
99. Mckenna WG, Weiss MC, Bakanauskas VJ, Sandler H, Kelsten ML, Biaglow J, Tuttle SW, Endlich B, Ling CC, Muschel RJ. 1990. The role of the H-ras oncogene in radiation resistance and metastasis. Int J Radiat Oncol Biol Phys 18:849-859.
100. 2 delay. Oncogene 12:237-245.
101. Miller AC, Kariko K, Myers CE, Clark EP, Samid D. 1993. Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation. Int J Cancer 53:302-307.
102. Nalca A, Qiu SGF, ElGuendy N, Krishnan S, Rangnekar VM. 1999. Oncogenic Ras sensitizes cells to apoptosis by Par-4. J Biol Chem 274:29976-29983.
103. Navarro P, Valverde AM, Benito M, Lorenzo M. 1999. Activated Ha-ras induces apoptosis by association with phosphorylated Bcl-2 in a mitogen-activated protein kinase-independent manner. J Biol Chem 274:18857-18863.
104. Nooter K, Boersma AWM, Oostrum RG, Burger H, Jochemsen AG, Stoter G. 1995. Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line. Br J Cancer 71:556-561.
105. Ohmori M, Shirasawa S, Furuse M, Okumura K, Sasazuki T. 1997. Activated Ki-ras enhances sensitivity of ceramide-induced apoptosis without c-Jun NH2-terminal kinase/stress-activated protein kinase or extracellular signal-regulated kinase activation in human colon cancer cells. Cancer Res 57:4714-4717.
106. Pal BK, Scherer L, Zelby L, Bertrand E, Rossi JJ. 1998. Monitoring retroviral RNA dimerization in vivo via hammerhead ribozyme cleavage. J Virol 72:8349-8353.
107. Parrizas M, Blakesley VA, BeitnerJohnson D, Leroith D. 1997a. The proto-oncogene Crk-II enhances apoptosis by a ras-dependent, Raf-1/MAP kinase-independent pathway. Biochem Biophys Res Commun 234:616-620.
108. Parrizas M, Saltiel AR, Leroith D. 1997b. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272:154-161.
109. Pervaiz S, Cao J, Chao OS, Chin YY, Clement MV. 2001. Activation of the RacGTPase inhibits apoptosis in human tumor cells. Oncogene 20:6263-6268.
110. Pirollo KF, Hao Z, Rait A, How CW, Chang EH. 1997. Evidence supporting a signal transduction pathway leading to the radiation-resistant phenotype in human tumor cells. Biochem Biophys Res Commun 230:196-201.
111. Pironin M, Clement G, Benzakour O, Barritault D, Lawrence D, Vigier P. 1992. Growth in serum-free medium of NIH3T3 cells transformed by the EJ-H-ras oncogene: Evidence for multiple autocrine growth factors. Int J Cancer 51:980-988.
112. Pongracz J, Tuffley W, Johnson GD, Deacon EM, Burnett D, Stockley RA, Lord JM. 1995. Changes in protein kinase C isoenzyme expression associated with apoptosis in U937 myelomonocytic cells. Exp Cell Res 218:430-438.
113. Premack BA, Gardner P. 1992. Signal transduction by T-cell receptors-Mobilization of Ca and regulation of Ca-dependent effector molecules. Am J Physiol 263:C1119-C1140.
114. Rajesh D, Schell K, Verma AK. 1999. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A. Mol Pharmacol 56:515-525.
115. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527-532.
116. Romashkova JA, Makarov SS. 1999. NF-kappa B is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90.
117. Ruvolo PP, Deng XM, Carr BH, May WS. 1998. A functional role for mitochondrial protein kinase C alpha in Bcl-2 phosphorylation and suppression of apoptosis. J Biol Chem 273:25436-25442.
118. Samid D, Miller AC, Rimoldi D, Gafner J, Clark EP. 1991. Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression. Radiat Res 126:244-250.
119. Sampson LE, Mire-Sluis A, Meager A. 1993. Protein kinase C-dependent phosphorylation is involved in resistance to tumour necrosis factor-alpha-induced cytotoxicity in a human monocytoid cell line. Biochem J 292:289-294.
120. Sandau KB, Callsen D, Brune B. 1999. Protection against nitric oxide-induced apoptosis in rat mesangial cells demands mitogen-activated protein kinases and reduced glutathione. Mol Pharmacol 56:744-751.
121. Sato N, Sakamaki K, Terada N, Arai K, Miyajima A. 1993. Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J 12:4181-4189.
122. Satoh T, Endo M, Nakafuku M, Akiyama T, Yamamoto T, Kaziro Y. 1990a. Accumulation of p21ras-GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci USA 87:7926-7929.
123. Satoh T, Endo M, Nakafuku M, Nakamura S, Kaziro Y. 1990b. Platelet-derived growth factor stimulates formation of active p21ras GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci USA 87:5993-5997.
124. Schwartz GK, Jiang J, Kelsen D, Albino AP. 1993. Protein kinase C: A novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst 85:402-407.
125. Schwieger A, Bauer L, Hanusch J, Sers C, Schafer R, Bauer G. 2001. Ras oncogene expression determines sensitivity for intercellular induction of apoptosis. Carcinogenesis 22:1385-1392.
126. Shao J, Sheng H, DuBois RN, Beauchamp RD. 2000. Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation. J Biol Chem 275:22916-22924.
127. Shen L, Glazer RI. 1998. Induction of apoptosis in glioblastoma cells by inhibition of protein kinase C and its association with the rapid accumulation of p53 and induction of the insulin-like growth factor-1-binding protein. Biochem Pharmacol 55:1711-1719.
128. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T. 1993. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260:85-88.
129. Shirokawa JM, Elisei R, Knauf JA, Hara T, Wang JW, Saavedra HI, Fagin JA. 2000. Conditional apoptosis induced by oncogenic ras in thyroid cells. Mol Endocrinol 14:1725-1738.
130. Sklar MD. 1988. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239:645-647.
131. Spandidos DA, Sourvinos G, Tsatsanis C, Zafiropoulos A. 2002. Normal ras genes: Their onco-suppressor and pro-apoptotic functions (review). Int J Oncol 21:237-241.
132. Suda T, Takahashi T, Golstein P, Nagata S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
133. 2+ oscillation in ras-transformed mouse fibroblasts. Exp Cell Res 203:230-235.
134. Susin SA, Zamzami N, Larochette N, Dallaporta B, Marzo I, Brenner C, Hirsch T, Petit PX, Geuskens M, Kroemer G. 1997. A cytofluorometric assay of nuclear apoptosis induced in a cell-free system: Application to ceramide-induced apoptosis. Exp Cell Res 236:397-403.
135. Tocque B, Delumeau I, Parker F, Maurier F, Multon MC, Schweighoffer F. 1997. Ras-GTPase activating protein (GAP): A putative effector for Ras, Cell Signal 9:153-158.
136. Trauth BC, Klas C, Peters AMJ, Matzuku S, Moller P, Falk W, Debatin KM, Krammer PH. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305.
137. Treisman R. 1986. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46:567-574.
138. Trent JC, McConkey DJ, Loughlin SM, Harbison MT, Fernandez A, Ananthaswamy HN. 1996. Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J 15:4497-4505.
139. Ulsh LS, Shih TY. 1984. Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. Mol Cell Biol 4:1647-1652.
140. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. 1996. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787-789.
141. van Blitterswijk WJ, Hilkmann H, Storme GA. 1987a. Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion. Lipids 22:820-823.
142. van Blitterswijk WJ, van der Bend RL, Kramer IM, Verhoeven AJ, Hilkmann H, de Widt J. 1987b. A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C. Lipids 22:842-846.
143. Viktorsson K, Heiden T, Molin M, Akusjarvi G, Linder S, Shoshan MC. 2000. Increased apoptosis and increased clonogenic survival of 12V-H-ras transformed rat fibroblasts in response to cisplatin. Apoptosis 5:355-367.
144. Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. 2000. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 275:35669-35672.
145. Wang SJ, Vrana JA, Bartimole TM, Freemerman AJ, Jarvis WD, Kramer LB, Krystal G, Dent P, Grant S. 1997. Agents that downregulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2. Mol Pharmacol 52:1000-1009.
146. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. 1998a. NF-kappa B antipoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
147. Wang Z, Gluck S, Zhang L, Moran MF. 1998b. Requirement for phospholipase C-gamma1 enzymatic activity in growth factor-induced mitogenesis. Mol Cell Biol 18:590-597.
148. Weiss A, Imboden J, Hardy K, Manger B, Terhorst C, Stobo J. 1986. The role of the T3/antigen receptor complex in T-cell activation. Annu Rev Immunol 4:593.
149. Weiss E, vonReyher U, Kittstein W, Moller P, Krammer PH, Marks F, Gschwendt M. 1997. Suppression of apoptosis in COLO 205 cells by the phorbol ester TPA may be mediated by the PKC isoenzyme alpha. Int J Oncol 10:1119-1123.
150. Woodgett JR, Avruch J, Kyriakis J. 1996. The stress activated protein kinase pathway. Cancer Surv 27:127-138.
151. Wyllie AH. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.
152. Xia ZG, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
153. Yang JY, Widmann C. 2001. Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol Cell Biol 21:5346-5358.
154. Yeh JH, Hsu SC, Han SH, Lai MZ. 1998. Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J Exp Med 188:1795-1802.
155. Yonehara S, Ishii A, Yonehara M. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756.
156. Zha JP, Harada H, Yang E, Jockel J, Korsmeyer SJ. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BGL-X(L). Cell 87:619-628.
157. Zhou T, Song L, Yang P, Wang Z, Lui D, Jope RS. 1999. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Nat Med 5:42-48.